linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Tata Consumer Products Ltd.
 
Source DateBoard Meeting DateDetails
27 Oct 202503 Nov 2025 Quarterly Results
16 Jul 202523 Jul 2025 Quarterly Results
17 Apr 202523 Apr 2025 Quarterly Results & Dividend & Audited Results
11 Oct 202418 Oct 2024 Quarterly Results
24 Jul 202430 Jul 2024 Quarterly Results
18 Jul 202423 Jul 2024 Right Issue of Equity Shares
12 Apr 202423 Apr 2024 Quarterly Results & Final Dividend & Audited Results
16 Jan 202407 Feb 2024 Quarterly Results
15 Jan 202419 Jan 2024 Inter alia, to consider and approve: 1. fund raising by debt issue in the form of commercial papers/debentures and equity issue through Rights Issue
09 Oct 202331 Oct 2023 Quarterly Results
03 Jul 202326 Jul 2023 Quarterly Results
10 Apr 202325 Apr 2023 Audited Results & Final Dividend
16 Jan 202302 Feb 2023 Quarterly Results
29 Sep 202220 Oct 2022 Quarterly Results
18 Jul 202210 Aug 2022 Quarterly Results
12 Apr 202204 May 2022 Final Dividend & Audited Results
24 Mar 202229 Mar 2022 Preferential Issue of shares
17 Jan 202202 Feb 2022 Quarterly Results
07 Oct 202122 Oct 2021Tata Consumer Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve In furtherance to our letter dated October 7, 2021 (intimating the date of Board Meeting for considering the financial results) and pursuant to the Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we hereby further inform you that the Board of Directors at its meeting scheduled on Friday, October 22, 2021, inter alia will also consider the Share Based Long-term Incentive Scheme for the eligible employees of the Company, subject to approval of shareholders, which would result into issuance of equity shares of the Company pursuant to the said Scheme.
16 Jul 202103 Aug 2021 Quarterly Results
Page 1 of 5
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.